Arysta Lifescience v EFSA

JUDGMENT OF THE GENERAL COURT (Seventh Chamber)18 June 2025 (*)( Access to documents – Regulation (EC) No 1049/2001 – Documents relating to the procedure for renewing the approval of the active substance captan – EFSA decision to disclose the full list of co-formulants present in the formulation for representative uses of the plant protection product Captan 80 WG referring to that substance – Exception relating to the protection of the commercial interests of a natural or legal person – Overriding public interest – Regulation (EC) No 1367/2006 – Information relating to emissions into the environment )In Case T‑222/23,Arysta Lifescience, established in Noguères (France), represented by D. Abrahams and Z. Romata, lawyers,applicant,v European Food Safety Authority (EFSA), represented by D. Detken, S. Gabbi and C. Pintado, acting as Agents, and by S. Raes, E. Kairis and Z. Lejeune, lawyers,defendant,supported by Claude Gruffat, residing in Mulsans (France),and Benoît Biteau, residing in Sablonceaux (France),represented by B. Kloostra, lawyer,interveners,THE GENERAL COURT (Seventh Chamber),composed of K. Kowalik‑Bańczyk, President, I. Dimitrakopoulos (Rapporteur) and B. Ricziová, Judges,Registrar: P. Cullen, Administrator,having regard to the order of 21 July 2023, Arysta Lifescience v EFSA (T‑222/23 R, not published, EU:T:2023:417),having regard to the written part of the procedure,further to the hearing on 6 February 2025,gives the following Judgment 1        By its action...